Alzheimer’s Disease :: Protein fingerprint in spinal fluid could spot Alzheimer’s disease
Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical “fingerprint,” which doctors might use someday to identify patients living with Alzheimer’s disease. The research will be published in the December online edition of the journal Annals of Neurology.